SIOPEN Publications
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: …
…A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Park JR, Villablanca JG, Hero B, Kushner BH, Wheatley K, Beiske KH, Ladenstein RL, Baruchel S, Macy ME, Moreno L, Seibel NL, Pearson AD, Matthay KK, Valteau-Couanet D.
Cancer. 2022 Nov 1;128(21):3775-3783. doi: 10.1002/cncr.34445. Epub 2022 Sep 13. PMID: 36101004
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of … (SIOPEN)
Sorrentino S, Ash S, Haupt R, Plantaz D, Schiff I, Hero B, Simon T, Kachanov D, Shamanskaya T, Kraal K, Littooij A, Wieczoreck A, Balwierz W, Laureys G, Trager C, Sertorio F, Erminio G, Fragola M, Beck Popovic M, De Bernardi B, Trahair T.
Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results.
Papadakis V, Segura V, Conte M, Plantaz D, Di Cataldo A, Schleiermacher G, Wheeler K, Bermúdez JD, Ash S, Brichard B, Ladenstein R, Combaret V, Sarnacki S, Fagnani AM, Granata C, Cañete A.
Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials
Wieczorek A., Manzitti C., Garaventa A., Gray J., Papadakis V., Valteau-Couanet D., Zachwieja K., Poetschger U., Pribill I., Fiedler S., Ladenstein R., Lode HN
Cancers (Basel) 2022, 14(8), 1919; https://doi.org/10.3390/cancers14081919, 2022 April 10 (link 2)
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children…
…With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N
Fredrik Sundquist Kleopatra Georgantzi, Kirsten Brunsvig Jarvis, Jesper Brok, Minna Koskenvuo, Jelena Rascon, Max van Noesel, Per Grybäck, Joachim Nilsson, Arthur Braat, Mikael Sundin, Sandra Wessman, Nikolas Herold, Lars Hjorth, Per Kogner, Dan Granberg, Mark Gaze, Jakob Stenman
Front Pediatr 2022 Mar 10;10:836230. doi: 10.3389/fped.2022.836230. eCollection 2022.
A Novel Standard for Systematic Reporting of Neuroblastoma Surgery: The International Neuroblastoma Surgical Report Form (INSRF): ...
A Joint Initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG, and GPOH
Lucas E Matthyssens, Jed G Nuchtern, Cees P Van De Ven, Hany O S Gabra, Kristin Bjornland, Sabine Irtan, Jakob Stenman, Luca Pio, Kate M Cross, Stefano Avanzini, Alessandro Inserra, Javier Gomez Chacon, Patrizia Dall'igna, Dietrich Von Schweinitz, Keith Holmes, Jorg Fuchs, Roly Squire, Dominique Valteau-Couanet, Julie R Park, Angelika Eggert, Paul D Losty, Michael P La Quaglia, Sabine Sarnacki, Surgical and Medical Committees of SIOPEN, COG and GPOH
Ann Surg. 2022 Mar 1;275(3):e575-e585. doi: 10.1097/SLA.0000000000003947.
Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelines.
Gabra HO, Irtan S, Cross K, Lobos P, Froeba-Pohl A, Pio L, Virgone C, Guillén Burrieza G, Gómez Chacón Villalba J, Riccipetitoni G, Guérin F, Nightingale M, Heloury Y, Faraj S, Leclair M, Scalabre A, Mattioli G, Warmann SW, Fuchs J, Basta N, Bjørnland K, Matthyssens LE, Losty PD, Sarnacki S.